Sputum-guided Treatment With Comprehensive Care Management in COPD - A Randomized-controlled Trial
This study aims to make life better for people with Chronic Obstructive Pulmonary Disease (COPD) who often have flare-ups. These flare-ups are a big reason people go to the hospital, and often come back soon after. This research is testing a new approach called 'sputum-guided treatment' alongside 'comprehensive care management'. This involves understanding more about your phlegm to guide treatment and getting lots of personal support to manage your condition better. We want to see if this combined approach can lead to fewer flare-ups compared to the usual care you would receive, ultimately helping you stay healthier and out of the hospital.
At a glance
What is this study about?
Chronic Obstructive Pulmonary Disease, or COPD, is a common lung condition that makes it hard to breathe. While there's no cure, managing your symptoms and avoiding flare-ups is key to living well. Unfortunately, many people with COPD experience flare-ups, which can lead to hospital stays, and sometimes people need to go back to the hospital soon after.
Flare-ups can happen for many reasons, and these can be different for each person. Sometimes it's about habits like smoking or not taking medicines as prescribed. Other times, it's due to swelling and irritation in the lungs. We know that teaching people about their condition and how to stay healthy, as well as using information from phlegm to choose the best medicines, can help. However, people still have flare-ups.
This study is trying a new approach to tackle this problem. We're looking closely at each person to make sure they're not only on the right medication but also getting the right support and advice to manage their condition effectively. The main aim is to see if a combination of personalised care, including guidance from your phlegm and overall health support, can help people have fewer COPD flare-ups compared to just receiving standard care.
Key takeaways
- This study aims to reduce COPD flare-ups and hospital visits.
- It combines tailored health support with individualised medicine choices based on phlegm samples.
- People with frequently worsening COPD are being invited to participate.
- Participants will receive either standard care or the new combined approach.
- The care management lasts for 6 months, with follow-up appointments.
- The goal is to improve the lives of people living with COPD.
Who may be eligible?
To join this study, you would need to have had COPD for some time. This means your doctor has diagnosed you with COPD based on breathing tests or scans of your lungs, and you have a history of smoking for at least 10 years.
Importantly, you must have had at least two severe flare-ups of your COPD in the past year that required medical attention or a hospital visit.
People would not be able to join if they have a severe mental health condition that isn't stable with medication, or if doctors expect their life expectancy to be less than six months.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Have you been diagnosed with COPD by a doctor?
- Have you smoked for at least 10 years in your life?
- Have you had at least two bad COPD flare-ups in the last year?
- Are you able to manage any mental health conditions with medication, if you have them?
- Are doctors expecting you to live for longer than six months?
What does participation involve?
If you join this study, you will be placed into one of two groups by chance: one group will receive standard care, and the other will receive the new 'sputum-guided treatment' combined with 'comprehensive care management'. This personalised care will last for about 6 months, and includes hospital and clinic visits. After leaving the hospital, you'll have clinic appointments at 2 weeks, 6 weeks, and 16 weeks.
For those in the new treatment group, the comprehensive care will involve a case manager, education to help you manage your own health, and help connecting with local support services. At your appointments, your phlegm will be checked to help guide which medicines might be best for your lung inflammation.
Potential risks and benefits
Locations (2)
- Hamilton General HospitalVerified postcodeHamilton, Canada· Not yet recruiting
- St. Joseph's Healthcare HamiltonVerified postcodeHamilton, Canada· Recruiting
Common questions
What is a COPD 'flare-up'?
A COPD flare-up is when your breathing suddenly gets much worse, and you might experience more coughing, wheezing, or feelings of breathlessness than usual. It often requires extra medication or a trip to the hospital.
What does 'sputum-guided treatment' mean?
This means your doctors will look at samples of your phlegm (sputum) to understand the type of inflammation in your lungs. This information helps them choose the most effective medicines for you.
What is 'comprehensive care management'?
This is extra support beyond regular doctor visits. It can include a case manager to help coordinate your care, education about managing your COPD, and help connecting with support groups or services in your community.
Will I get to choose which treatment group I'm in?
No, you won't get to choose. You will be assigned to either the standard care group or the new treatment group by chance, like flipping a coin. This helps make the study fair.
How long will I be involved in the study?
The main part of the new care will last for about 6 months, with specific check-up appointments during that time. The overall study will follow participants for longer to collect important information.
How to find out more
Terence N Ho, MB, MSc
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.